Visual Abstract
Abstract
IgG4-related disease (IgG4-RD) is a highly heterogeneous autoimmune disease. Recently, 2 subtypes of IgG4-RD, proliferative and fibrotic, were defined according to patients’ clinicopathologic characteristics. The purpose of this study was to determine the difference in fibroinflammatory activity shown on 68Ga-FAPI-04 and 18F-FDG PET/CT in the proliferative and fibrotic IgG4-RD subtypes. Methods: Thirty-seven newly diagnosed IgG4-RD patients (29 of the proliferative subtype and 8 of the fibrotic subtype) who had undergone 68Ga-FAPI-04 and 18F-FDG PET/CT were enrolled. SUVmax and target-to-background ratio (TBR) of IgG4-RD lesions were measured. To evaluate the weight of fibroinflammatory activity, the PET index of a lesion was calculated as the quotient of SUVmax or TBR of 68Ga-FAPI-04 and that of 18F-FDG. For the assessment of the global disease in an individual patient, the PET index was defined as the ratio of SUVmean of all involved lesions in 68Ga-FAPI-04 PET/CT to that in 18F-FDG. Results: The 18F-FDG uptake values of the most prominent lesions in the proliferative and fibrotic subtypes were similar; however, the proliferative subtype showed significantly higher uptake of 68Ga-FAPI-04 than did the fibrotic subtype (SUVmax, 17.67 ± 7.46 vs. 10.93 ± 2.22, P = 0.005; TBR, 15.49 ± 8.23 vs. 9.25 ± 3.00, P = 0.015). The PET index of proliferative-subtype patients was higher than that of fibrotic-subtype patients (1.46 ± 0.41 vs. 1.14 ± 0.39, P = 0.039). The PET index of pancreatobiliary disease was significantly higher than that of head-and-neck disease, fibrosis or aortitis, lymph nodes, and another disease subtype (P < 0.05). After first-line treatment, patients with a PET index of at least 1.5 had significantly shorter relapse-free survival than those with a PET index of less than 1.5 (22.0 mo vs. not reached, P < 0.0001; hazard ratio, 13.46; 95% CI, 2.236–81.03). Conclusion: The proliferative subtype of IgG4-RD had a greater weight of fibroinflammatory activity than that of the fibrotic subtype. The PET index, a marker of the weight of fibroinflammatory activity, is predictive of relapse-free survival of IgG4-RD.
Footnotes
Published online Mar. 6, 2025.
- © 2025 by the Society of Nuclear Medicine and Molecular Imaging.
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
SNMMI members
Login to the site using your SNMMI member credentials
Individuals
Login as an individual user